DAPAFLOZIN M10/500

Dapaflozin M 10/500 is a combination of Dapagliflozin (10 mg) and Metformin Hydrochloride (500 mg) designed to help manage Type 2 Diabetes Mellitus effectively. It offers a synergistic effect for better glycemic control in adults who are unable to control their blood sugar levels with Metformin alone.

This dual-acting oral antidiabetic medication enhances insulin sensitivity and promotes urinary glucose excretion, supporting blood sugar reduction and potential weight loss.

Key Benefits:

• Powerful combination of SGLT2 inhibitor + Metformin

• Helps lower HbA1c levels effectively

• Aids in weight management and cardiovascular support

• Lowers the risk of hypoglycemia

• Ideal for add-on therapy to diet and exercise